These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30745235)

  • 1. How reliable is your HbA1c test? Revisiting the use of HbA1c in cystic fibrosis-related diabetes (CFRD) screening.
    Lam GY; Sissons S; Smith MP; Brown NE; Leung WM; Estey MP
    J Cyst Fibros; 2019 Mar; 18(2):e14-e15. PubMed ID: 30745235
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.
    Boudreau V; Coriati A; Desjardins K; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Mar; 15(2):258-60. PubMed ID: 26905501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.
    Holl RW; Buck C; Babka C; Wolf A; Thon A
    Diabetes Care; 2000 Jan; 23(1):126. PubMed ID: 10857983
    [No Abstract]   [Full Text] [Related]  

  • 4. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis related diabetes: Revisiting the OGTT and alternate screening tests.
    Chan CL
    J Cyst Fibros; 2020 Sep; 19(5):671-672. PubMed ID: 32713805
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
    Yung B; Kemp M; Hooper J; Hodson ME
    Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.
    Hunkert F; Lietz T; Stach B; Kiess W
    Diabetes Care; 1999 Jun; 22(6):1008-10. PubMed ID: 10372264
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes.
    Christian F; Thierman A; Shirley E; Allen K; Cross C; Jones K
    J Investig Med High Impact Case Rep; 2019; 7():2324709619842898. PubMed ID: 31010313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.
    Racine F; Shohoudi A; Boudreau V; Nguyen CQT; Denis MH; Desjardins K; Reynaud Q; Rabasa-Lhoret R; Mailhot G
    Can J Diabetes; 2021 Dec; 45(8):768-774. PubMed ID: 33926819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal screening of patients with cystic fibrosis-related diabetes in Wales -- a real eye opener.
    Roberts R; Speight L; Lee J; George L; Ketchell RI; Lau D; Duckers J
    J Cyst Fibros; 2015 Mar; 14(2):282-4. PubMed ID: 25224328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening.
    Lam GY; Doll-Shankaruk M; Dayton J; Rodriguez-Capote K; Higgins TN; Thomas D; Mulchey K; Smith MP; Brown NE; Leung WM; Estey MP
    J Cyst Fibros; 2018 Jan; 17(1):121-124. PubMed ID: 28648493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Methods for Diagnosing Cystic Fibrosis-Related Diabetes: A Network Meta-Analysis of Diagnostic Accuracy Studies.
    Izsák VD; Soós A; Szakács Z; Hegyi P; Juhász MF; Varannai O; Martonosi ÁR; Földi M; Kozma A; Vajda Z; Shaw JA; Párniczky A
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33807165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of HbA1c measurements.
    Bartlett WA; Jones AF; Hall RA; Legg EF
    Diabet Med; 2000 Jul; 17(7):558-60. PubMed ID: 10972596
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
    Gilmour JA; Sykes J; Etchells E; Tullis E
    Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment.
    Alves C; Della-Manna T; Albuquerque CTM
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):835-843. PubMed ID: 32651985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.
    Mohan K; Miller H; Burhan H; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2008 Jul; 43(7):642-7. PubMed ID: 18500737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Where are we now with the quantitation of HbA1c?].
    Gillery P
    Journ Annu Diabetol Hotel Dieu; 2005; ():125-9. PubMed ID: 16161312
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased detection of cystic-fibrosis-related diabetes in Australia.
    Rana M; Munns CF; Selvadurai HC; Simonds S; Cooper PJ; Woodhead HJ; Hameed S; Verge CF; Lafferty AR; Crock PA; Craig ME
    Arch Dis Child; 2011 Sep; 96(9):823-6. PubMed ID: 21653750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic Fibrosis-Related Diabetes in Children: An Update.
    Kim RJ
    Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.